Vivi Kasim

Key Laboratory Of Biorheological Science And Technology
Chongqing, 400044, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Stem-like characteristics across sequentially temozolomide-adapted glioblastoma cell populations with increasing levels of acquired resistance.

Stem-like characteristics across sequentially temozolomide-adapted glioblastoma cell populations with increasing levels of acquired resistance.

Journal: Molecular biology reports

Published: April 19, 2026

YAP-mediated mechanotransduction promotes hepatocellular carcinoma progression by targeting ATP1A1/CXCL1 axis.

YAP-mediated mechanotransduction promotes hepatocellular carcinoma progression by targeting ATP1A1/CXCL1 axis.

Journal: Acta pharmacologica Sinica

Published: March 16, 2026

Salidroside suppresses hyperglycemia-induced M1 macrophage polarization to accelerate diabetic wound healing by restraining mTOR pathway.

Salidroside suppresses hyperglycemia-induced M1 macrophage polarization to accelerate diabetic wound healing by restraining mTOR pathway.

Journal: International immunopharmacology

Published: February 10, 2026

Publisher Correction: NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation.

Publisher Correction: NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation.

Journal: Oncogene

Published: September 22, 2025

Unstructured but critical: The role of YY1 and YY2 disorder in promoter recognition networks, transcriptional control, and oncogenesis.

Unstructured but critical: The role of YY1 and YY2 disorder in promoter recognition networks, transcriptional control, and oncogenesis.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: August 14, 2025

YY1: Master regulator of metabolic reprogramming in cancer.

YY1: Master regulator of metabolic reprogramming in cancer.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: August 01, 2025

Yin Yang 1 (YY1) as a Central Node in Drug Resistance Pathways: Potential for Combination Strategies in Cancer Therapy.

Yin Yang 1 (YY1) as a Central Node in Drug Resistance Pathways: Potential for Combination Strategies in Cancer Therapy.

Journal: Biomolecules

Published: June 28, 2025

NFATc1-mediated activation of the pentose phosphate pathway and cell cycle dysregulation collectively drive tumor progression.

NFATc1-mediated activation of the pentose phosphate pathway and cell cycle dysregulation collectively drive tumor progression.

Journal: Oncogenesis

Published: May 26, 2025

Salidroside analogue C-30 promotes neovascularization in diabetic hindlimb ischemic mice by inducing macrophage M2 polarization.

Salidroside analogue C-30 promotes neovascularization in diabetic hindlimb ischemic mice by inducing macrophage M2 polarization.

Journal: International immunopharmacology

Published: May 19, 2025

NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation.

NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation.

Journal: Oncogene

Published: March 02, 2025

PBX3-HMGCR Axis Promotes Hepatocellular Carcinoma Progression Through Enhancing De Novo Cholesterol Biosynthesis.

PBX3-HMGCR Axis Promotes Hepatocellular Carcinoma Progression Through Enhancing De Novo Cholesterol Biosynthesis.

Journal: International journal of molecular sciences

Published: February 23, 2025

Author Correction: An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA.

Author Correction: An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA.

Journal: Nature

Published: January 28, 2025

Showing 1-12 of 67

Last Updated: 09/26/2026